This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,390.00, is for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a medical product. The contract has an ultimate completion date of April 29, 2025 and is a Firm Fixed Price, Delivery Order contract type. The contract is not designated with a set-aside requirement, indicating open...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. under the company's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract is for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a pharmaceutical product, with a firm-fixed price of $1,387.50 and a ceiling value of $1,387.50. The delivery order does not have a set-aside designation and is expected to be completed by August 13,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,147.20, is for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML medical supplies. The contract has an ultimate completion date of May 27, 2025. AmerisourceBergen Drug Corp, a for-profit organization headquartered in Conshohocken, Pennsylvania, is a critical supplier of medical and pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a pharmaceutical product. The contract has a ceiling value of $5,052.60 and runs through September 30, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, and this contract is part of the...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a medical product, with a total ceiling value of $1,625.20. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of June 11, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,836.04 firm fixed price contract is for the supply of RHOPHYLAC, a 300 mcg/2 mL syringe medication, with an ultimate completion date of October 15, 2024. The award does not utilize a set-aside designation. AmerisourceBergen holds multiple Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, collectively valued up to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML. The contract has a firm fixed price of $1,377.03 and an ultimate completion date of August 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...
The U.S. Department of Defense's Medical Supply Chain, also known as the Defense Logistics Agency (DLA) Troop Support Medical, awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML pharmaceuticals. The $4,590.10 contract has an ultimate completion date of April 2, 2024. AmerisourceBergen Drug Corp is the prime contractor and has also received an indefinite delivery contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,377.03 firm fixed price delivery order is for the provision of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a pharmaceutical product, with a period of performance through April 24, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a medical product. The contract, valued at $1,380.52, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense (DoD). The contract has an ultimate completion date of August 14, 2024, and is structured as a Firm Fixed Price Delivery Order. Amerisourcebergen is a well-established federal...